ILA 83.4
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Operating as a research and development partnership, Imed Infinity Medical-Limited Partnership was founded in 2020 and is located in Tel Aviv, Israel. Its central mission involves providing capital for R&D ventures within the medical domain, especially those focused on digital health.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is 'cheap' on EV/EBITDA.
Data is available to registered users only